Humana Inc. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.Humana Inc. (HUM) shares fell 1.04% to $378.02, marking its third consecutive day of losses and closing 11.86% below its 52-week high. Despite the decline, Humana outperformed competitors like UnitedHealth Group and Chubb Ltd., which also dropped, while Elevance Health rose slightly. Trading volume was below the 50-day average. This occurred during a generally favorable market session where the S&P 500 and Dow Jones Industrial Average both gained.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Humana Inc. (HUM) slid 1.04% to $378.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,707.98 and the Dow Jones Industrial Average rising 0.22% to 53,463.05.
This was the stock's third consecutive day of losses.
Humana Inc. closed 11.86% below its 52-week high of $428.88, which the company achieved on July 16th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as UnitedHealth Group Inc. (UNH) fell 1.35% to $388.61, Elevance Health Inc. (ELV) rose 0.05% to $398.45, and Chubb Ltd. (CB) fell 1.27% to $340.92.
Trading volume (1.1 M) remained 291,719 below its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-19-26 1652ET